UA88795C2 - Гетероциклические соединения, которые применяются для лечения воспалителных и аллергических нарушений - Google Patents

Гетероциклические соединения, которые применяются для лечения воспалителных и аллергических нарушений

Info

Publication number
UA88795C2
UA88795C2 UAA200707953A UAA200707953A UA88795C2 UA 88795 C2 UA88795 C2 UA 88795C2 UA A200707953 A UAA200707953 A UA A200707953A UA A200707953 A UAA200707953 A UA A200707953A UA 88795 C2 UA88795 C2 UA 88795C2
Authority
UA
Ukraine
Prior art keywords
allergic
treatment
pharmaceutically acceptable
reperfusion injury
inflammatory
Prior art date
Application number
UAA200707953A
Other languages
English (en)
Ukrainian (uk)
Inventor
Лаксмікант Атмарам Гхарат
Баласубраманіан Гопалан
Нііліма Кхаіраткар-Йоші
Original Assignee
Гленмарк Фармасьютікалс С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гленмарк Фармасьютікалс С.А. filed Critical Гленмарк Фармасьютікалс С.А.
Publication of UA88795C2 publication Critical patent/UA88795C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Изобретение касается новых ингибиторов фосфодиэстеразы 4 типа (PDE-4) формулы (1) EMBED ISISServer , (1) а также их аналогов, таутомеров, энантиомеров, диастереомеров, региоизомеров, стереоизомеров, полиморфных модификаций, фармацевтически приемлемых солей, которые отвечают N-оксидам и фармацевтически приемлемым сольватам указанных веществ, а также фармацевтических композиций, содержащих указанные соединения, которые применяются для лечения аллергических и воспалительных состояний, включающих астму, хронический бронхит, атопический дерматит, крапивницу, аллергический ринит, аллергический конъюнктивит, весенний конъюнктивит, эозинофильную гранулему, псориаз, ревматоидный артрит, септический шок, язвенный колит, болезнь Крона, реперфузионное поражение миокарда и реперфузионное поражение мозга, хронический гломерулонефрит, эндотоксический шок и респираторный дистресс-синдром у взрослых.
UAA200707953A 2004-12-17 2005-12-15 Гетероциклические соединения, которые применяются для лечения воспалителных и аллергических нарушений UA88795C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1352MU2004 2004-12-17

Publications (1)

Publication Number Publication Date
UA88795C2 true UA88795C2 (ru) 2009-11-25

Family

ID=38658137

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200707953A UA88795C2 (ru) 2004-12-17 2005-12-15 Гетероциклические соединения, которые применяются для лечения воспалителных и аллергических нарушений

Country Status (9)

Country Link
US (1) US7943634B2 (ru)
CN (1) CN101124229B (ru)
DK (1) DK1831227T3 (ru)
ES (1) ES2417491T3 (ru)
NO (1) NO20073436L (ru)
PT (1) PT1831227E (ru)
SI (1) SI1831227T1 (ru)
UA (1) UA88795C2 (ru)
ZA (1) ZA200706097B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1620429E (pt) * 2003-04-11 2009-04-28 Glenmark Pharmaceuticals Sa Novos compostos heterocíclicos úteis para o tratamento de perturbações inflamatórias e alérgicas: processo para a sua preparação e composições farmacêuticas que os contêm
WO2008142542A2 (en) * 2007-05-22 2008-11-27 Glenmark Pharmaceuticals, S.A. Processes for preparing benzofuro [3, 2-c] pyridine- 9-carbaldehyde derivatives as novel intermediates for the synthesis of pde iv inhibitors
CN103864779B (zh) * 2012-12-07 2016-06-22 天津科技大学 一种1-(苯基)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚衍生物的制备及其在抗肿瘤药物中的应用
CN103864781A (zh) * 2012-12-13 2014-06-18 天津科技大学 一种新型1，9-二取代四氢咔啉类衍生物的制备及其抗肿瘤药物中的应用
CN104961742B (zh) * 2015-03-17 2017-04-12 丁新生 具有防治阿尔茨海默病作用的化合物及其应用
CN106883270B (zh) 2015-11-26 2019-03-26 财团法人工业技术研究院 有机金属化合物、包含其的有机发光装置
CN113754675B (zh) * 2020-06-04 2022-09-02 首都医科大学 二甲基二氧六环-四氢-β-咔啉-3-羧酸的合成,生物活性和应用
CN116514824A (zh) * 2022-01-29 2023-08-01 上海科技大学 三并环类化合物、其制备方法和用途

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1041861A (en) 1962-03-14 1966-09-07 Organon Labor Ltd Pyrrolidone derivatives and pharmaceutical preparations containing them
NL7008628A (ru) 1969-06-25 1970-12-29
US3759948A (en) * 1969-06-25 1973-09-18 Merck & Co Inc Non-steroid anti-inflammatory compounds
NL7016899A (ru) 1969-12-03 1971-06-07
US3846553A (en) * 1969-12-03 1974-11-05 Merck & Co Inc 3-substituted-2-pyridones in the treatment of pain, fever or inflammation
US4222944A (en) * 1978-07-31 1980-09-16 Hoffmann-La Roche Inc. Halo-3-dibenzofuran alkanonitriles
JPS62158253A (ja) 1985-12-28 1987-07-14 Kirin Brewery Co Ltd ４−アミノピリジンアミド誘導体
JPH0812430B2 (ja) 1986-07-07 1996-02-07 キヤノン株式会社 電子写真感光体
EP0257956B2 (en) * 1986-08-19 2000-11-22 Genentech, Inc. Use of polypeptide growth factors and cytokines for the manufacture of a device and of a dispersion
US5202344A (en) 1990-12-11 1993-04-13 G. D. Searle & Co. N-substituted lactams useful as cholecystokinin antagonists
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
US5602173A (en) 1992-04-02 1997-02-11 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
NZ254881A (en) 1992-07-28 1996-09-25 Rhone Poulenc Rorer Ltd Diether, dithioether or diether thioether derivatives of 1,2-dihydroxybenzenes substituted in position-4 by an (hetero)aryl-containing group;
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
GB9304920D0 (en) 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
KR100331255B1 (ko) 1993-07-02 2002-10-25 빅굴덴 롬베르그 케미쉐 화부리크 게엠베하 플루오로알콕시-치환된벤즈아미드및시클릭뉴클레오티드포스포디에스테라아제억제제로서의그의용도
GB9315595D0 (en) 1993-07-28 1993-09-08 Res Inst Medicine Chem New compounds
WO1995009837A1 (en) 1993-10-01 1995-04-13 Smithkline Beecham Corporation Cyano compounds
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
GB9404706D0 (en) 1994-03-11 1994-04-27 Smithkline Beecham Corp Compounds
CN1166169A (zh) 1994-07-27 1997-11-26 三共株式会社 用作毒蕈碱性受体别构效应物的杂环化合物
EE03997B1 (et) * 1995-04-14 2003-04-15 Glaxo Wellcome Inc. Albuterooli doseeriv inhalaator
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DE19616573C2 (de) * 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
EP0931045A1 (en) 1996-09-04 1999-07-28 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
JP3530004B2 (ja) * 1998-02-06 2004-05-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
AP2000001919A0 (en) 1998-03-19 2000-09-30 Vertex Pharma Inhibitors of caspases.
US6110962A (en) * 1998-05-12 2000-08-29 American Home Products Corporation 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho[2,3-D]thiophenes useful in the treatment of insulin resistance and hyperglycemia
WO1999058521A1 (en) 1998-05-12 1999-11-18 American Home Products Corporation 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
CA2401870A1 (en) 2000-03-17 2001-09-27 Bristol-Myers Squibb Pharma Company Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha.
US6924292B2 (en) 2000-03-23 2005-08-02 Takeda Chemical Industries, Ltd. Furoisoquinoline derivatives, process for producing the same and use thereof
WO2002060867A2 (en) 2001-01-29 2002-08-08 Insight Strategy And Marketing Ltd Carbazole derivatives and their uses as heparanase inhibitors
AU2002306687A1 (en) 2001-03-13 2002-09-24 Glenmark Pharmaceuticals Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO2004016596A1 (en) 2002-08-19 2004-02-26 Glenmark Pharmaceuticals Limited Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders
AU2003263393A1 (en) 2002-09-04 2004-03-29 Glenmark Pharmaceuticals Limited New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
CN100532374C (zh) * 2002-10-23 2009-08-26 格兰马克药品有限公司 可用于治疗炎性和变应性病症的新的三环化合物:它们的制备方法以及包含它们的药物组合物
WO2004069831A1 (en) * 2003-02-10 2004-08-19 Glenmark Pharmaceuticals Ltd. Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation
PT1620429E (pt) * 2003-04-11 2009-04-28 Glenmark Pharmaceuticals Sa Novos compostos heterocíclicos úteis para o tratamento de perturbações inflamatórias e alérgicas: processo para a sua preparação e composições farmacêuticas que os contêm

Also Published As

Publication number Publication date
US7943634B2 (en) 2011-05-17
US20090306082A1 (en) 2009-12-10
SI1831227T1 (sl) 2013-09-30
CN101124229B (zh) 2012-07-18
ZA200706097B (en) 2008-07-30
PT1831227E (pt) 2013-08-23
ES2417491T3 (es) 2013-08-08
NO20073436L (no) 2007-09-05
CN101124229A (zh) 2008-02-13
DK1831227T3 (da) 2013-08-19

Similar Documents

Publication Publication Date Title
TW200634015A (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
UA88795C2 (ru) Гетероциклические соединения, которые применяются для лечения воспалителных и аллергических нарушений
CN106995443B (zh) 新组合物、用途和制备它们的方法
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
TW200508212A (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
CA2975196A1 (en) 1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as trpa1 antagonists
US9815832B2 (en) Azabenzimidazole compounds
TW200610757A (en) New pyridazin-3(2H)-one derivatives
TNSN07251A1 (en) 2-phenyl-indoles as prostaglandin d2 receptor antagonists
MX2008011369A (es) Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2.
WO2010084402A3 (en) Heterocyclic compounds as phosphodiesterase inhibitors
AU2010339423A1 (en) Therapeutic compounds and related methods of use
KR20170018913A (ko) 리신 특이적 데메틸라제-1의 억제제
AU2019289222B2 (en) Pyrazole derivatives as MALT1 inhibitors
UA88485C2 (en) 2,6-substituted-4-monosubstituted amino-pyrimidines as prostaglandin d2 receptor antagonists
NO20065948L (no) Quinazolin-4-yl-piperidin- and cinnolin-4-yl-piperidin-derivatives som PDE10-inhibitorer for behandling av CNS forstyrrelser
CN103415513A (zh) 白三烯产物的苯并二氧杂环己烷抑制剂
WO2012114268A1 (en) Benzamide derivatives as p2x7 receptor antagonists
EA200900472A1 (ru) Ингибиторы фосфодиэстеразы iv типа
CA2906262A1 (en) Macrocyclic salt-inducible kinase inhibitors
CA2960777A1 (en) Macrocyclic lrrk2 kinase inhibitors
WO2018021977A1 (en) Glycine metabolism modulators and uses thereof
WO2009115874A3 (en) Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
IL297767A (en) Novel imidazolones as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4
ES2250750T3 (es) Aroil piridinonas.